StonvexLoading…
StonvexStonvexStonvexCore line items from NRXP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.07M | $1.23M | $242.00K | $0.00 |
Operating Income | $-4.74M | $-16.22M | $-11.60M | $-7.58M |
Net Income | $-1.43M | $-28.62M | $-28.98M | $-17.58M |
EPS (Diluted) | $-0.04 | $-1.34 | $-1.54 | $-1.34 |
Total Assets | $11.90M | $12.96M | $15.00M | $4.84M |
Total Liabilities | $25.72M | $28.89M | $40.75M | $40.45M |
Cash & Equivalents | $6.71M | $7.80M | $7.18M | $2.91M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 33.47M | 31.73M | 27.68M | 19.47M |